Abstract
Helicobacter pylori infection is associated with increased risk for gastric cancer. Whether H. pylori eradication affects this risk is unknown. To explore this issue, investigators in Japan evaluated changes in gastric intestinal metaplasia (GIM) and cellular markers of neoplasia after eradication. Endoscopic biopsies were used to confirm H. pylori infection and to classify the 96 study participants into three groups: All patients received proton-pump inhibitor–based triple …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
